Hypnosis in Parkinson’s Disease

Journal title IPNOSI
Author/s Marco Mozzoni
Publishing Year 2018 Issue 2018/1
Language Italian Pages 10 P. 41-50 File size 175 KB
DOI 10.3280/IPN2018-001003
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

This paper reviews the most recent literature on the use of clinical hypnosis as a complementary therapy in the treatment of patients suffering from Parkinson’s Disease (PD) and movement disorders. The prevalence of the disease, the most common signs and symptoms, and neuropathology are described. In addition, traditional therapies and complementary therapies, to which patients are increasingly directed, are illustrated. In the context of the mind-body medicine approach, hypnosis results an effective method and may also help to improve the conditions of patients with PD, naturally linked to this therapeutic approach by the phenomenon of temporal distortion and its neurobiological correlates.

Keywords: Hypnosis, mind-body, neurodegeneration, Parkinson, parkinsonisms.

  1. Elkins G., Sliwinski J., Bowers J., Encarnacion E. (2013). Feasibility of clinical hypnosis for the treatment of Parkinson’s disease: a case study. International Journal of Clinical and Experimental Hypnosis, 61(2): 172-182. DOI: 10.1080/00207144.2013.753829
  2. Elkins G. (2017). Handbook of Medical and Psychological Hypnosis: Foundations, Applications, and Professional Issues. New York: Springer Publishing Company.
  3. Facco E. (2014). Meditazione e ipnosi. Tra neuroscienze, filosofia e pregiudizio. Lungavilla: Altravista.
  4. Flamand-Roze C., Célestin-Lhopiteau I., Roze E. (2016). Hypnosis and movement disorders: State of the art and perspectives, Reveu Neurologique, 172(8-9): 530-536.
  5. Fox M. (2008). Always Looking Up. The Adventures of an Incurable Optimist. New York: Hyperion.
  6. Gonzalez-Usigli H.A., Parkinson’s Disease. In: Porter S., ed., Merck Manual. Milano: Raffaello Cortina. -- https://www.merckmanuals.com/professional/neurologic -disorders/movement-and-cerebellar-disorders/parkinson-disease
  7. Lewis P., Miall R. (2006). A right hemispheric prefrontal system for cognitive time measurement. Behavioural Processes, 71: 226-234.
  8. Lisak R., Truong D., Carroll W., Bhidayasiri R. (2016). International Neurology. Stati Uniti: Wiley-Blackwell.
  9. Rajput A.H., Rajput M., Ferguson L., Rajput A. (2017). Baseline motor findings and Parkinson disease prognostic subtypes. Neurology, 89(2): 138-143. DOI: 10.1212/WNL.0000000000004078
  10. Schlesinger I., Benyakov O., Erikh I., Suraiya S., Schiller Y. (2009). Parkinson’s disease tremor is diminished with relaxation guided imagery. Movement Disorder Society, 24(14): 2059-2062.
  11. Sliwinsky J. (2017). Parkinson’s Disease. In: Elkins G., ed., Handbook of Medical and Psychological Hypnosis: Foundations, Applications, and Professional Issues. New York: Springer Publishing Company.
  12. Vanhaudenhuyse A., Laureys S., Faymonville M. (2014). Neurophysiology of hypnosis. Neurophysiologie Clinique, 44(4): 343-353.
  13. Wahbeh H., Elsas S., Oken B. (2008). Mind-body interventions: applications in neurology. Neurology, 70(24): 2321-2328.
  14. Wain H., Amen D., Jabbari B. (1990). The effects of hypnosis on a parkinsonian tremor: case report with polygraph/EEG recordings. American Journal of Clinical Hypnosis, 33(2): 94-98. DOI: 10.1080/00029157.1990.10402910
  15. Ajimsha M., Majeed N., Chinnavan E., Thulasyammal R. (2014). Effectiveness of autogenic training in improving motor performances in Parkinson’s disease. Complementary Therapies in Medicine, 22(3): 419-425.
  16. Bhatia K.P, Ray Chaudhuri K.R, Stamelou M. (2017). Parkinson’s Disease. International Review of Neubobiology, 132: 2-253.
  17. Bran L., Owens J., Williamson A. (2012). The Handbook of Contemporary Clinical Hypnosis: Theory and Practice. Stati Uniti: Wiley-Blackwell.
  18. Cojan Y., Waber L., Schwartz S., Rossier L., Forster A., Vuilleumier P. (2009). The brain under self-control: modulation of inhibitory and monitoring cortical networks during hypnotic paralysis. Neuron, 62(6): 862-875.
  19. De Virgilio A., Greco A., Fabbrini G., Inghilleri M., Rizzo M., Gallo A., Conte M., Rosato C., Ciniglio Appiani M., De Vincentis M. (2016). Parkinson’s disease: Autoimmunity and neuroinflammation. Autoimmunity Reviews, 15(10): 1005-1011.
  20. Deng H., Wang P., Jankovi J. (2018). The genetics of Parkinson disease. Ageing Research Reviews, 42: 72-85.
  21. Wilkinson I. (2005). Essential Neurology. Stati Uniti: Wiley-Blackwell Publishing.
  22. Yard S., Duhamel K., Galynker I. (2008). Hypnotizability as a potential risk factor for posttraumatic stress: a review of quantitative studies. International Journal of Clinical and Experimental Hypnosis, 56: 334-356. DOI: 10.1080/00207140802042007

Marco Mozzoni, Ipnosi e Parkinson in "IPNOSI" 1/2018, pp 41-50, DOI: 10.3280/IPN2018-001003